Reduction of Right Ventricular Pacing Using the Feature Ventricular Intrinsic Preference (VIP)

Completed · Not applicable

Conditions studied: Bradycardia

In brief

The purpose of this study is to evaluate the efficacy of the VIP™ feature (available in dual chamber Victory® devices) to reduce unnecessary RV pacing, and to determine if patients with implanted SJM pacemakers will benefit by using VIP™ rather than only a programmed AV/PV delay.

Key facts

Study ID

NCT00311168

Run by

Abbott Medical Devices

People needed

135

Starts

2006-02-01

Expected to finish

2008-09-01

Last updated by the study team

2021-08-12

Who can join

Age: 18 and older, up to 100. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient has been implanted with dual chamber SJM Victory® device with VIP™ for 1 month (± 2 weeks).
• At the time of pacemaker implant, VIP™ is programmed "OFF".
• At the time of enrollment, patient is paced in the RV ≤ 60% of the time.
• Patient is medically stable.

You may not qualify if…

• Patient has evidence of complete AV block, such that ventricular pacing would be required as part of the patient's routine management.
• Patient is indicated for AF Suppression.
• Patient has persistent or chronic atrial fibrillation.
• Patient is unable to comply with the follow-up visits due to geographical, psychological, or any other reasons.
• Patient is currently participating in another device research study.
• Patient is younger than 18 years of age.
• Patient is pregnant.
• Patients life expectancy is less than 12 months.

Where it is running

• Abbott — Sylmar, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.